Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The Antimicrobial Peptides market revenue was 168 Million USD in 2019, and will reach 395 Million USD in 2025, with a CAGR of 15.28% during 2020-2025. Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Antibacterial and Antimicrobial have some different function, antibacterial only kill bacteria and antimicrobial kill all microorganisms.
This report elaborates the market size, market characteristics, and market growth of the Antimicrobial Peptides industry, and breaks down according to the type, application, and consumption area of Antimicrobial Peptides. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antimicrobial Peptides in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Antimicrobial Peptides market covered in Chapter 11:
Merck & Co., Inc.
GenScript Biotech Corporation
Roche Holding AG
Shenzhen Sunsmile Biotechnology Co.,Ltd
GeneLinx International, Inc.
InvivoGen
Linzhou Sinagri Yingtai Biological Peptide Co., Ltd.
Sigma-Aldrich Corporation
Abeona Therapeutics Inc.
EnBiotix, Inc.
In Chapter 3, on the basis of types, the Antimicrobial Peptides market from 2015 to 2025 is primarily split into:
Recombinant
Natural
In Chapter 4, on the basis of applications, the Antimicrobial Peptides market from 2015 to 2025 covers:
Pharmaceutical
Animal Feed
Food Additive
Agriculture
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
2019
This report elaborates the market size, market characteristics, and market growth of the Antimicrobial Peptides industry, and breaks down according to the type, application, and consumption area of Antimicrobial Peptides. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.
In Chapter 2.3 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Antimicrobial Peptides in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
Chapter 2.5 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 6-10 consider the impact of COVID-19 on the regional economy.
Key players in the global Antimicrobial Peptides market covered in Chapter 11:
Merck & Co., Inc.
GenScript Biotech Corporation
Roche Holding AG
Shenzhen Sunsmile Biotechnology Co.,Ltd
GeneLinx International, Inc.
InvivoGen
Linzhou Sinagri Yingtai Biological Peptide Co., Ltd.
Sigma-Aldrich Corporation
Abeona Therapeutics Inc.
EnBiotix, Inc.
In Chapter 3, on the basis of types, the Antimicrobial Peptides market from 2015 to 2025 is primarily split into:
Recombinant
Natural
In Chapter 4, on the basis of applications, the Antimicrobial Peptides market from 2015 to 2025 covers:
Pharmaceutical
Animal Feed
Food Additive
Agriculture
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10:
North America (Covered in Chapter 6)
United States
Canada
Mexico
Europe (Covered in Chapter 7)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 8)
China
Japan
South Korea
Australia
India
Middle East and Africa (Covered in Chapter 9)
Saudi Arabia
UAE
Egypt
South Africa
South America (Covered in Chapter 10)
Brazil
Argentina
Columbia
Years considered for this report:
Historical Years:
2015-2019Base Year:
2019Estimated Year:
2020Forecast Period:
2020-2025Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
